questionText: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the UK’s capacity to attract investment in dementia clinical trials, in the context of the availability of disease-modifying treatments in other countries that have not yet been approved for use by the NHS.
answerText: No particular assessment has been made.The Department is committed to turbocharging medical research and delivering better patient care, to make the United Kingdom a world-leading destination for clinical research. We are working to fast-track clinical tr...
heading: Dementia: Clinical Trials